On Tuesday, Anixa Biosciences Inc (NASDAQ: ANIX) was 26.46% up from the session before settling in for the closing price of $3.25. A 52-week range for ANIX has been $2.07 – $4.20.
Healthcare Sector giant saw their annual sales surged by 7.73% over the last five years. When this article was written, the company’s average yearly earnings per share was at 8.97%. With a float of $31.13 million, this company’s outstanding shares have now reached $32.82 million.
Anixa Biosciences Inc (ANIX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Anixa Biosciences Inc stocks. The insider ownership of Anixa Biosciences Inc is 5.43%, while institutional ownership is 16.34%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,800. In this transaction Director of this company bought 10,000 shares at a rate of $3.08, taking the stock ownership to the 953,334 shares. Before that another transaction happened on Jul 30 ’25, when Company’s Chief Executive Officer bought 5,000 for $3.16, making the entire transaction worth $15,800. This insider now owns 579,925 shares in total.
Anixa Biosciences Inc (ANIX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 10/31/2024, it has been observed that the corporation posted -0.09 earnings per share (EPS) during the time that was better than consensus figure (set at -0.11) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.42% during the next five years compared to 7.73% growth over the previous five years of trading.
Anixa Biosciences Inc (NASDAQ: ANIX) Trading Performance Indicators
You can see what Anixa Biosciences Inc (ANIX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.34, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Anixa Biosciences Inc (ANIX)
Analysing the last 5-days average volume posted by the [Anixa Biosciences Inc, ANIX], we can find that recorded value of 0.3 million was better than the volume posted last year of 0.11 million. As of the previous 9 days, the stock’s Stochastic %D was 41.85%.
During the past 100 days, Anixa Biosciences Inc’s (ANIX) raw stochastic average was set at 94.83%, which indicates a significant increase from 90.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.16, while its 200-day Moving Average is $2.96. Now, the first resistance to watch is $4.42. This is followed by the second major resistance level at $4.74. The third major resistance level sits at $5.27. If the price goes on to break the first support level at $3.57, it is likely to go to the next support level at $3.04. Should the price break the second support level, the third support level stands at $2.72.
Anixa Biosciences Inc (NASDAQ: ANIX) Key Stats
There are 32,917K outstanding shares of the company, which has a market capitalization of 135.29 million. As of now, sales total 0 K while income totals -12,550 K. Its latest quarter income was 0 K while its last quarter net income were -2,260 K.
